These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Economic evaluation of intravenous iodinated contrast media in Italy. Iannazzo S; Vandekerckhove S; De Francesco M; Nayak A; Ronco C; Morana G; Valentino M Int J Technol Assess Health Care; 2014 Jan; 30(1):69-77. PubMed ID: 24485022 [TBL] [Abstract][Full Text] [Related]
23. Frequency and effects of extravasation of ionic and nonionic CT contrast media during rapid bolus injection. Federle MP; Chang PJ; Confer S; Ozgun B Radiology; 1998 Mar; 206(3):637-40. PubMed ID: 9494479 [TBL] [Abstract][Full Text] [Related]
24. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. Wang CL; Cohan RH; Ellis JH; Caoili EM; Wang G; Francis IR AJR Am J Roentgenol; 2008 Aug; 191(2):409-15. PubMed ID: 18647910 [TBL] [Abstract][Full Text] [Related]
25. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000 [TBL] [Abstract][Full Text] [Related]
26. Intravenous excretory urography using Optiray in office urology. Koncz PM Int Urol Nephrol; 1995; 27(3):257-60. PubMed ID: 7591587 [TBL] [Abstract][Full Text] [Related]
27. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Boccalandro F; Amhad M; Smalling RW; Sdringola S Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698 [TBL] [Abstract][Full Text] [Related]
28. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE; Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951 [TBL] [Abstract][Full Text] [Related]
29. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282 [TBL] [Abstract][Full Text] [Related]
30. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563 [TBL] [Abstract][Full Text] [Related]
31. Acute severe thrombocytopenia following non-ionic low-osmolarity intravenous contrast medium injection. Bata P; Tarnoki AD; Tarnoki DL; Horvath E; Berczi V; Szalay F Korean J Radiol; 2012; 13(4):505-9. PubMed ID: 22778575 [TBL] [Abstract][Full Text] [Related]
32. Intravenous contrast agents and associated changes in serum osmolality. George M; Shannon M Pediatr Emerg Care; 2009 Sep; 25(9):555-7. PubMed ID: 19755886 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. Reed PS; Dixon SR; Boura JA; O'Neill WW; Kahn JK Am J Cardiol; 2007 Oct; 100(7):1090-3. PubMed ID: 17884368 [TBL] [Abstract][Full Text] [Related]
34. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268 [TBL] [Abstract][Full Text] [Related]
35. Oral contrast for abdominal computed tomography in children: the effects on gastric fluid volume. Mahmoud M; McAuliffe J; Kim HY; Mishra P; Salisbury S; Schnell B; Hirsch P; Arbabi S; Donnelly LF Anesth Analg; 2010 Nov; 111(5):1252-8. PubMed ID: 20736428 [TBL] [Abstract][Full Text] [Related]
36. Safety profile and protocol prevention of adverse reactions to uroangiographic contrast media in diagnostic imaging. Rossi C; Reginelli A; D'Amora M; Di Grezia G; Mandato Y; D'Andrea A; Brunese L; Grassi R; Rotondi A J Biol Regul Homeost Agents; 2014; 28(1):155-65. PubMed ID: 24750802 [TBL] [Abstract][Full Text] [Related]
38. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. Ng CS; Shaw AD; Bell CS; Samuels JA AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198 [TBL] [Abstract][Full Text] [Related]
39. Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT. Ho YF; Hsieh KL; Kung FL; Wu FL; Hsieh LL; Chou H; Chen SJ AJR Am J Roentgenol; 2015 Oct; 205(4):703-8. PubMed ID: 26397318 [TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media. Zhang BC; Wu Q; Wang C; Li DY; Wang ZR J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]